$0.00
CJC-1295 DAC is an investigational peptide engineered to mimic the activity of naturally occurring growth hormone-releasing hormone (GHRH). The addition of a Drug Affinity Complex (DAC) extends its biological half-life, allowing researchers to study sustained activation of the GHRH receptor and its effects on endogenous growth hormone signaling.
Researchers continue to investigate how prolonged GHRH receptor stimulation may influence growth hormone physiology, insulin-like growth factor-1 (IGF-1) signaling, metabolic regulation, body composition, and healthy aging. Its long-acting design has made CJC-1295 DAC an important tool in endocrine and metabolic research.
These represent areas of ongoing scientific research and are not established clinical uses.
Store refrigerated at 2–8°C (36–46°F). Protect from excessive heat, moisture, and direct sunlight. After reconstitution, follow established laboratory handling and storage procedures.
CJC-1295 DAC has become a significant focus of endocrine research because its Drug Affinity Complex (DAC) technology extends its duration of action compared to traditional GHRH analogs. Researchers continue to investigate how sustained GHRH receptor activation influences endogenous growth hormone secretion, IGF-1 signaling, and metabolic physiology. Its extended-acting profile has established CJC-1295 DAC as a valuable peptide for studying long-term endocrine regulation.
For laboratory research use only. Not for human consumption. This product is intended exclusively for qualified laboratory and scientific research. It is not intended to diagnose, treat, cure, or prevent any disease.
$0.00
$0.00
$0.00
$0.00